Literature DB >> 17969000

Lung disease in Niemann-Pick disease.

Nathalie Guillemot1, Corinne Troadec, Thierry Billette de Villemeur, Annick Clément, Brigitte Fauroux.   

Abstract

BACKGROUND: Lung involvement in children with Niemann-Pick disease has rarely been studied systematically.
OBJECTIVE: To assess the involvement of the lung and the value of bronchoalveolar lavage in children with Niemann-Pick diseases.
DESIGN: Retrospective analysis of patient records. PATIENTS: Thirteen patients, with type A (n = 1), type B (n = 10), and type C (n = 2) Niemann-Pick disease, aged 2 months to 9 years at diagnosis, were included in the study.
INTERVENTIONS: Lung involvement was assessed by clinical evaluation, chest radiograph, lung computed tomography (CT) scan, pulmonary function tests, and bronchoalveolar lavage fluid analysis.
RESULTS: Respiratory symptoms were present at diagnosis in 10 patients and developed during follow up in the three other patients. All patients showed signs of interstitial lung disease on chest X-ray and lung CT scan. Bronchoalveolar lavage fluid analysis (n = 7) revealed a marked accumulation of foamy macrophages (Niemann-Pick cells) in all patients. At follow up, one patient died of respiratory failure, five patients required long term oxygen therapy and seven other patients presented a chronic obstructive pulmonary disease (n = 6) or chronic cough (n = 1).
CONCLUSION: Lung disease was observed in all the patients included in the present study. Bronchoalveolar lavage may be useful in Niemann-Pick diseases by showing the presence of characteristic Niemann-Pick cells.

Entities:  

Mesh:

Year:  2007        PMID: 17969000     DOI: 10.1002/ppul.20725

Source DB:  PubMed          Journal:  Pediatr Pulmonol        ISSN: 1099-0496


  29 in total

1.  Therapeutic potential of cyclodextrins in the treatment of Niemann-Pick type C disease.

Authors:  Benny Liu
Journal:  Clin Lipidol       Date:  2012-06

Review 2.  Pulmonary Involvement in Niemann-Pick Disease: A State-of-the-Art Review.

Authors:  Felipe Mussi von Ranke; Heloisa Maria Pereira Freitas; Alexandre Dias Mançano; Rosana Souza Rodrigues; Bruno Hochhegger; Dante Escuissato; Cesar Augusto Araujo Neto; Thiago Krieger Bento da Silva; Edson Marchiori
Journal:  Lung       Date:  2016-05-10       Impact factor: 2.584

3.  Niemann-Pick disease type C in the newborn period: a single-center experience.

Authors:  Ersin Gumus; Goknur Haliloglu; Asuman Nur Karhan; Hulya Demir; Figen Gurakan; Meral Topcu; Aysel Yuce
Journal:  Eur J Pediatr       Date:  2017-09-27       Impact factor: 3.183

4.  Pulmonary involvement in Niemann-Pick C type 1.

Authors:  Orna Staretz-Chacham; M Aviram; I Morag; A Goldbart; E Hershkovitz
Journal:  Eur J Pediatr       Date:  2018-07-31       Impact factor: 3.183

Review 5.  [Interstitial processes of the lungs in childhood].

Authors:  H Popper
Journal:  Pathologe       Date:  2017-07       Impact factor: 1.011

6.  Ontogenic changes in lung cholesterol metabolism, lipid content, and histology in mice with Niemann-Pick type C disease.

Authors:  Charina M Ramirez; Adam M Lopez; Lam Q Le; Kenneth S Posey; Arthur G Weinberg; Stephen D Turley
Journal:  Biochim Biophys Acta       Date:  2013-09-26

7.  Pulmonary function and pathology in hydroxypropyl-beta-cyclodextin-treated and untreated Npc1⁻/⁻ mice.

Authors:  Akshay Muralidhar; Ivan A Borbon; Dyadin M Esharif; Wangjing Ke; Rinu Manacheril; Michael Daines; Robert P Erickson
Journal:  Mol Genet Metab       Date:  2011-03-05       Impact factor: 4.797

Review 8.  Interstitial lung diseases in children.

Authors:  Annick Clement; Nadia Nathan; Ralph Epaud; Brigitte Fauroux; Harriet Corvol
Journal:  Orphanet J Rare Dis       Date:  2010-08-20       Impact factor: 4.123

9.  Imaging of Childhood Interstitial Lung Disease.

Authors:  R Paul Guillerman
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2010-03       Impact factor: 1.349

Review 10.  Lysosomal storage diseases--the horizon expands.

Authors:  Rose-Mary Naaman Boustany
Journal:  Nat Rev Neurol       Date:  2013-08-13       Impact factor: 42.937

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.